Skip Navigation LinksHome > May 24, 2002 - Volume 16 - Issue 8 > Rates of non-AIDS-defining cancers in people with HIV infect...
AIDS:
Epidemiology & Social

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis

Grulich, Andrew E.; Li, Yueming; McDonald, Ann; Correll, Patricia K. L.; Law, Matthew G.; Kaldor, John M.

Free Access
Article Outline
Collapse Box

Author Information

From the National Centre in HIV Epidemiology and Clinical Research, the University of New South Wales, Sydney, Australia.

Correspondence to Dr Andrew Grulich, National Centre in HIV Epidemiology and Clinical Research, Level 2, 376 Victoria St, Sydney, NSW 2010 Australia. Tel: +61 2 9332 4648; fax: +61 2 9332 1837; email: agrulich@nchecr.unsw.edu.au

Received: 1 October 2001;

revised: 3 January 2002; accepted: 14 January 2002.

Sponsorship: The National Centre in HIV Epidemiology and Clinical Research is funded by the Commonwealth Department of Health and Ageing.

Collapse Box

Abstract

Objective: To describe the incidence of non-AIDS-defining cancers in people with HIV infection before and after the occurrence of AIDS, and to examine the association of cancer risk with immune deficiency.

Design: Cohort study involving nation-wide linkage of HIV, AIDS and cancer registry data.

Methods: Association of cancer risk with immune deficiency was examined by analysing cancer risks in four periods between HIV diagnosis, AIDS and death.

Results: Linkage identified 196 cases of non-AIDS-defining cancer in 8351 people notified with HIV infection and 8118 registered with AIDS (total of 13 067 individuals). Overall, we found significantly increased rates of cancer of the lip, anus, Hodgkin's disease, myeloma and leukaemia. Of these cancers, in people with HIV infection who did not develop AIDS, or were more than 5 years prior to development of AIDS, only cancer of the anus occurred at increased rates. A significant trend of increasing relative risk of cancer with increasing time since HIV diagnosis was found for Hodgkin's disease and multiple myeloma.

Conclusions: People with HIV with mild immune deficiency prior to AIDS were at increased risk of anal cancer, but this may reflect other risk factors. Other cancers occurred only later in the course of HIV infection. This is reassuring evidence that people with HIV who are only mildly immune deficient may not be at increased risk of non-AIDS-defining cancers, but larger studies with longer periods of follow-up are needed to confirm this.

Back to Top | Article Outline

Introduction

Studies that have linked AIDS and cancer registries have provided valuable information on the spectrum of malignant disorders associated with advanced HIV infection [1–4]. Since the mid-1990s, the introduction of potent antiretroviral therapy has lead to reductions in AIDS incidence, of more than 70% in treated cohorts [5,6]. Consequently, in countries with good access to antiretroviral therapies, people diagnosed with AIDS now represent an increasing minority of people with HIV, and most people with HIV are now living with only mild to moderate degrees of immune deficiency for extended periods of time without developing AIDS.

To gain a clearer understanding of morbidity, including cancer, that occurs prior to the occurrence of advanced immune deficiency, it is therefore important that studies of people with HIV include both people with and without AIDS. Although large cohort studies of populations with HIV have contributed some data on the spectrum of malignant diseases associated with HIV [7], linkage studies of HIV and cancer registries have not yet been reported.

In Australia, there has been a nation-wide registration of cancer since 1980 and notification of HIV diagnosis since 1985. We performed a population-based linkage study between databases relating to HIV infection and AIDS and cancer registries to assess the relative risk of non-AIDS-defining cancer in HIV-infected people in Australia. In particular, we aimed to describe cancer incidence in people with early HIV disease, a stage of HIV disease in which cancer incidence has been little studied.

Back to Top | Article Outline

Materials and methods

In Australia, HIV and AIDS are reported with a name code (first two letters of first and last name), date of birth and sex. We attempted linkage for all those individuals who had complete data for these three fields on either the national HIV or AIDS database. The procedure of linkage with the cancer register has been described in detail previously [8]. Briefly, linkage was performed using a modified version of the national cancer register, with full names converted to name codes. A match was accepted if there was an exact match on all three fields, or there was a near match supported by consistency between the registers in dates of death and area of residence. Linkage was performed separately for the HIV and AIDS databases. HIV and AIDS data were available to December 1999, and cancer data until 1995 to 1998 depending on jurisdiction. The sex, age and HIV risk behaviour of individuals included in the analysis is presented in Table 1.

Table 1
Table 1
Image Tools

Cancer incidence rates were calculated using the person–years methods. For each type of cancer, person–years at risk were calculated as outlined in Table 2. Exploratory analyses showed that calculated rates of cancer in the 5 years prior to AIDS diagnosis gave cancer rates which were unbiased estimates of cancer rates in people with HIV infection before AIDS diagnosis [9]. For this reason, all people recorded as having AIDS were assumed to have had HIV infection for 5 years before the AIDS diagnosis, and to be under follow-up for the purpose of the estimation of cancer incidence. Thus, for a person with a date of AIDS diagnosis who did not appear on the HIV register, follow-up began 5 years prior to date of AIDS. Standardized incidence ratios (SIRs) were calculated based on age-, sex-, year- and state-specific incidence rates of cancer in the general population. Confidence intervals and time trends were estimated assuming that the observed cancers were Poisson distributed [10].

Table 2
Table 2
Image Tools

To assess the association between cancer incidence and immune deficiency, four time periods were defined based on increasing HIV disease progression. A single individual could contribute to each of the time periods, depending on available follow-up. Period one (least immune deficient) was defined as the period from date of registered HIV infection to 5 years prior to date of AIDS, or the entire period from HIV infection in those who were not recorded as having progressed to AIDS during follow-up. Period two was from 5 years to 6 months prior to AIDS diagnosis. Period three spanned 6 months either side of AIDS diagnosis, and period four (most immune deficient) was from 6 months to 2 years after AIDS diagnosis. Trends in cancer risk over these periods were assessed separately including and excluding the 6-month period around AIDS, to allow for the possibility that diagnostic bias might increase diagnosis of cancer around the time of diagnosis of AIDS.

Back to Top | Article Outline

Results

By August 1999, 46% (8108) of people reported with HIV, and 100% of people with AIDS, had a name code, date of birth and sex recorded and were therefore eligible for linkage with the cancer registry. In total, 1355 cancers, including 196 non-AIDS-defining cancers, were registered in 13 067 people with HIV or AIDS. Results for AIDS-defining cancers have been presented elsewhere [11].

SIRs in people with HIV and/or AIDS are shown in Table 3. There were significantly increased rates of several cancers, including cancer of lip (10 cases, nine of which were squamous cell carcinoma), anus (10 cases, eight of which were squamous cell carcinoma), connective tissue (20 cases, 10 of which had no histological confirmation, five were haemangiosarcomata, and one sarcoma not specified), Hodgkin's disease (15 cases, of which six were of mixed cellularity, three lymphocyte depleted, one nodular sclerosis, and five were not specified), myeloma, and leukaemia (13 cases including a variety of subtypes with no more than three of each subtype). SIRs were not significantly raised for lung cancer (17 cases, of which six were large cell, four were squamous cell, and three were adenocarcinoma) and cancer of the testis (10 cases, of which seven were seminoma). Rates of colon cancer were significantly decreased (three cases).

Table 3
Table 3
Image Tools

Overall, 37% of person–years were in period 1 (least immune deficient), 46% in period 2, 9.0% in period 3, and 7.4% in period 4 (most immune deficient). In period 1, rates were significantly increased only for cancer of the anus, liver and testis (first column of Table 4). Incidence rates of most cancers were increased in period 3 (the period 6 months either side of AIDS). Of the cancers that occurred at increased rates overall, there were significant increasing trends in cancer rates across the four periods for connective tissue cancer, Hodgkin's disease and multiple myeloma. If the period including the 6 months around AIDS was excluded, a significantly increasing trend was only seen for connective tissue cancer.

Table 4
Table 4
Image Tools
Back to Top | Article Outline

Discussion

This study is the first to report linkage between population-based HIV and cancer registers. By separately linking data from both the HIV and AIDS registers, we were able to examine cancer rates across the spectrum of HIV infection from mild to severe immune deficiency, thereby extending the results of previous AIDS–cancer linkage studies. Thirty-seven percent of the total person–years of follow-up were in period one, which consisted of people at a less advanced stage of HIV infection than those included in previous linkage studies. Most of the person–years in this period (92%) were in those who never developed AIDS during follow-up rather than those who were HIV-positive for more than 5 years before AIDS. In this period of early HIV infection, of the cancers that occurred at increased rates overall, incidence was increased only for anal cancer, a disease known to occur at increased rates in HIV-negative homosexual men, who have been estimated to comprise about 85% of people with HIV in Australia [12]. The absence of increases in rates in period one of cancers that were increased in later HIV infection, such as cancer of the lip and Hodgkin's disease, is somewhat reassuring that mild immune deficiency is not associated with increased cancer risk. We demonstrated a significant association of cancer risk with increasing immune deficiency over the four time periods for Hodgkin's disease, multiple myeloma, and connective tissue cancer, but there was reason to believe the association may have been related to diagnostic confusion with Kaposi's sarcoma for connective tissue cancer.

The main limitation of this study is its low power, despite the inclusion of 46% of people with HIV and all people notified with AIDS in Australia. Only 41 cancers were documented in the least immune deficient follow-up period. Another limitation was that our dataset contains very little data on HIV-infected women: in Australia only 7% of all HIV diagnoses to 1999 had been in women [12]. It is likely that linkage identified the great majority of pathologically diagnosed cancers, as we have previously demonstrated that our matching procedure is highly sensitive and specific for identifying non-Hodgkin's lymphoma (NHL) in people with AIDS [8]. It is likely that the matching would be similarly efficient for identifying cancers usually diagnosed pathologically. We have also demonstrated that AIDS registration in Australia is 97% complete for individuals diagnosed with AIDS–NHL [8], so it is unlikely that a substantial proportion of our cohort had AIDS that had not been registered as such.

Anal cancer is aetiologically related to infection with oncogenic subtypes of human papilloma viruses, and an increased risk in homosexual men was well described before the HIV epidemic [13]. Although risk of anal intra-epithelial neoplasia has been associated with a degree of immune deficiency in cohort studies of homosexual men HIV infection [14], risk of carcinoma in situ and of invasive cancer was not associated with time before and after AIDS diagnosis in the largest AIDS–cancer linkage study [15], and did not tend to occur near the time of AIDS diagnosis in a cohort study [16]. In our study, anal cancer rates increased from HIV diagnosis to the time around AIDS diagnosis, but there were no diagnoses more than 6 months after AIDS. Even in people with the mildest degree of immune deficiency rates of this cancer were increased 20-fold above that expected. Thus, our data do not support an independent association between invasive anal cancer and HIV-associated immune deficiency, but it may be that prolonged observation will be necessary. In transplant recipients, anogenital cancers occur at increased rates and appear much later after transplantation than do Kaposi's sarcoma and NHL [17].

Rates of Hodgkin's disease have been described as occurring at elevated rates in several cohort and linkage studies [1–4,16] and an association of risk with increasing immune deficiency has been previously reported [3,4]. Our finding that there were no cases of Hodgkin's disease in people in period one adds strength to the hypothesis that Hodgkin's disease is related to immune deficiency in people with HIV infection. This is supported by findings in clinical studies that Hodgkin's disease tends to occur at a median CD4 positive T-cell count of 200–300 × 106 cells/l [18].

Lip cancer occurs at increased rates in immune-suppressed transplant recipients [19] and shares aetiological risk factors with squamous cell carcinoma of the skin, which occurs at greatly increased rates in transplant recipients [20]. Increased rates of lip cancer in people with AIDS have been described in Australia and the US [3,4]. The fact that rates were not increased in period one in this study is reassuring, but further study is needed to determine whether rates may be increased in long-term survivors of HIV infection. Cohort studies of people with HIV should collect data on lip cancer, and on skin cancers, to help determine whether these cancers will become a long term complication of HIV infection, as they are of long term iatrogenic immune suppression [20]. As data on non-melanoma skin cancers are collected by few cancer registries, it is essential that data on these cancers are collected in cohort studies of people with HIV.

There have been several case series of multiple myeloma occurring in people with AIDS but there are few data from cohort studies. The largest reported AIDS–cancer linkage study found that incidence was raised 2.6-fold but it did not increase significantly from the pre- to post-AIDS period [4]. An AIDS–cancer linkage study in Italy did not find an increased risk of myeloma [2].

Apart from anal cancer, Hodgkin's disease, lip cancer and multiple myeloma, there were other cancers that occurred at increased rates but there was reason to believe that the increased rates may not have reflected a true increase in incidence. For connective tissue cancers, 50% of registered cancers were not histologically confirmed, and many of those that were confirmed were haemangiosarcomata or unspecified sarcoma, and may have been diagnostically confused with Kaposi's sarcoma. For brain cancer, four of the sven diagnoses occurred around AIDS diagnosis, and as two of these four had no histological confirmation, there may have been diagnostic confusion with NHL.

There have been several cohort studies of cancer incidence in HIV-infected people, some without an AIDS diagnosis [7,16,21], but these have not reported on associations between immune deficiency and cancer, nor have they reported separately on cancer incidence by time period before or after AIDS diagnosis. Previous AIDS–cancer linkage studies [1–4] are unable to contribute data on the incidence of cancer in people with early HIV infection, and the tendency for cancer diagnosis to occur near the time of AIDS diagnosis shown in these and the current study may lead to over-estimation of the overall magnitude of the association between non-AIDS-defining cancers and AIDS.

As the incidence of AIDS has decreased among people with HIV treated with potent antiretroviral therapy, it has become important that other causes of morbidity are documented. The increasingly long-term survival of people with HIV with mild immune deficiency requires us to examine whether or not they will experience increased risk of certain cancers. Data from transplant recipients suggests that certain cancers, in particular cancers of the anogenital region and skin, may occur at increased rates. Although our study provides some reassurance that cancer rates are not markedly increased in early HIV infection, linkage of cancer and HIV registers in larger populations over a long duration of follow-up will be necessary to further document the cancer experience of this population, and the association between mild immune deficiency and cancer.

Back to Top | Article Outline

Acknowledgements

The authors wish to acknowledge the assistance of the Australian Institute of Health and Welfare, and the South Australian Cancer Register, who undertook the record linkage component of this work, and the National HIV Surveillance Committee. The National HIV Surveillance Committee comprises the following State/Territory and national representatives: Ms Irene Passaris (ACT); Mr Robert Menzies (NSW); Dr Jan Savage (NT); Dr Hugo Ree (QLD); Ms Therese Davey (SA); Mr Neil Cremasco (TAS); Ms Cathy Keenan (VIC); Dr Gary Dowse (WA); Professor John Kaldor (NCHECR) and Ms Ann McDonald (NCHECR).

Back to Top | Article Outline

References

1. Goedert JJ, Cote TR, Virgo P. et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998, 358: 1833–1839.

2. Franceschi S, Dal Maso L, Arniani S. et al. Risk for cancer other than KS and NHL in persons with AIDS in Italy. Brit J Cancer 1998, 78: 966–970.

3. Grulich A, Wan X, Law M, Coates M, Kaldor J. Cancer incidence rates in people with AIDS in NSW, Australia. AIDS 1999, 13: 839–843.

4. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001, 285: 1736–1745.

5. Egger M, Hirschel B, Francioli P. et al. Impact of new anti-retroviral therapies in HIV infected patients in Switzerland: prospective cohort study. BMJ 1997, 315: 1194–1199.

6. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999, 13: 1933–1942.

7. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW and the Adult/Adolescent Spectrum of HIV Disease Project Group. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr 1999, 21: S11–S17.

8. Grulich AE, Wan X, Coates M, Day P, Kaldor JM. Validation of a non-identifying method of linking cancer and AIDS register data. J Epidemiol Biostat 1996, 1: 207–212.

9. Li Y, Law M, McDonald A, Correll P, Kaldor JM, Grulich AE. Estimation of non-AIDS defining cancer incidence in people with HIV infection prior to the occurrence of AIDS. Am J Epidemiol 2002, 155: 153–158.

10. Breslow NE, Day N. Statistical methods in cancer research, Volume 2- the design and analysis of cohort studies. Lyon: IARC; 1987

11. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Decreasing rates of HIV-associated Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of highly active anti-retroviral therapy: national linkage study. AIDS 2001, 15: 629–633.

12. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia, Annual Surveillance Report 1999. Sydney: NCHECR, UNSW; 1999.

13. Biggar RJ, Melbye M. Marital status in relation to Kaposi's sarcoma, non-Hodgkin's lymphoma and anal cancer in the pre-AIDS era. J Acquir Immune Defic Syndr Hum Retrovir, 1996, 11: 178–182.

14. Critchlow CW, Surawicz CM, Holmes KK. et al. Prospective study of high grade anal squamous intra-epithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995, 9: 1255–1262.

15. Frisch M, Biggar RJ, Goedert JJ. Human papilloma virus- associated cancers in patients with HIV infection and AIDS. JNCI 2000, 92: 1500–1510.

16. Koblin BA, Hessol NA, Zauber AG. et al. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978–1990. Am J Epidemiol 1996, 144: 916–923.

17. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986, 58: 611–616.

18. Rabkin CS, Blattner WA. HIV infection and cancers other than non-Hodgkin's lymphoma and Kaposi's sarcoma. Cancer Surveys 1991, 10: 151–163.

19. Birkeland SA, Storm HH, Lamm LU. et al. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer 1995, 60: 183–189.

20. London NJ, Farmery SM, Will EJ, Davison AM, Lodge PA. Risk of neoplasia in renal transplant recipients. Lancet 1995, 346: 403–406.

21. Serraino D, Boschini A, Carrieri P. et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000, 14: 553–559.

Cited By:

This article has been cited 96 time(s).

Bmc Cancer
Anal cytological abnormalities and epidemiological correlates among men who have sex with men at risk for HIV-1 infection
Dona, MG; Benevolo, M; Vocaturo, A; Palamara, G; Latini, A; Giglio, A; Moretto, D; Rollo, F; Impara, G; Ensoli, F; Pimpinelli, F; Di Carlo, A; Giuliani, M
Bmc Cancer, 12(): -.
ARTN 476
CrossRef
Clinics in Chest Medicine
Human Immunodeficiency Virus-Associated Lung Malignancies
Lambert, AA; Merlo, CA; Kirk, GD
Clinics in Chest Medicine, 34(2): 255-+.
10.1016/j.ccm.2013.01.008
CrossRef
Hiv Medicine
Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD)
Petoumenos, K; van Leuwen, MT; Vajdic, CM; Woolley, I; Chuah, J; Templeton, DJ; Grulich, AE; Law, MG
Hiv Medicine, 14(2): 77-84.
10.1111/j.1468-1293.2012.01038.x
CrossRef
Clinical Lymphoma Myeloma & Leukemia
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma in HIV-Positive Patients in the Highly Active Antiretroviral Therapy Era: The Myeloma Institute of Research and Therapy Experience
Muzaffar, J; Usmani, S; Abdallah, AO; Anaissie, E; Cottler-Fox, M; Restrepo, A
Clinical Lymphoma Myeloma & Leukemia, 13(2): 171-174.
10.1016/j.clml.2012.12.004
CrossRef
International Journal of Epidemiology
Commentary: The changing face of AIDS
May, M
International Journal of Epidemiology, 31(5): 959-960.

Scandinavian Journal of Infectious Diseases
Hodgkin's disease in the setting of human immunodeficiency virus infection
Calza, L; Manfredi, R; Colangeli, V; Dentale, N; Chiodo, F
Scandinavian Journal of Infectious Diseases, 35(2): 136-141.

American Journal of Epidemiology
Cancer in a population-based cohort of men and women in registered homosexual partnerships
Frisch, M; Smith, E; Grulich, A; Johansen, C
American Journal of Epidemiology, 157(): 966-972.
10.1093/aje/kwg067
CrossRef
British Journal of Cancer
Risk of cancer in persons with AIDS in Italy, 1985-1998
Del Maso, L; Franceschi, S; Polsel, J; Braga, C; Piselli, P; Crocetti, E; Falcini, F; Guzzinati, S; Zanetti, R; Vercelli, M; Rezza, G
British Journal of Cancer, 89(1): 94-100.
10.1038/sj.bjc.6601017
CrossRef
Cancer Epidemiology Biomarkers & Prevention
Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome
Goedert, JJ; Purdue, MP; McNeel, TS; McGlynn, KA; Engels, EA
Cancer Epidemiology Biomarkers & Prevention, 16(6): 1266-1269.
10.1158/1055-9965.EPI-07-0042
CrossRef
Bju International
Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study
Pantanowitz, L; Bohac, G; Cooley, TP; Aboulafia, D; Dezube, BJ
Bju International, 101(): 1519-1523.
10.1111/j.1464-410X.2008.07474.x
CrossRef
Hematology-Oncology Clinics of North America
Epidemiology of AIDS-related malignancies - An international perspective
Mbulaiteye, SM; Parkin, DM; Rabkin, CS
Hematology-Oncology Clinics of North America, 17(3): 673-+.
10.1016/S0889-8588(03)00048-0
CrossRef
Clinical Infectious Diseases
HIV infection is associated with an increased risk for lung cancer, independent of smoking
Kirk, GD; Merlo, C; O' Driscoll, P; Mehta, SH; Galai, N; Vlahov, D; Samet, J; Engels, EA
Clinical Infectious Diseases, 45(1): 103-110.
10.1086/518606
CrossRef
Revue Du Praticien
HIV infection and comorbidities
Lacombe, K; Pacanowski, J
Revue Du Praticien, 56(9): 995-1004.

AIDS
Risk of cancers during interrupted antiretroviral therapy in the SMART study
Silverberg, MJ; Neuhaus, J; Bower, M; Gey, D; Hatzakis, A; Henry, K; Hidalgo, J; Lourtau, L; Neaton, JD; Tambussi, G; Abrams, DI
AIDS, 21(): 1957-1963.

Blood
Hodgkin lymphoma in the Swiss HIV Cohort Study
Clifford, GM; Rickenbach, M; Lise, M; Dal Maso, L; Battegay, M; Bohlius, J; El Amari, EB; Karrer, U; Jundt, G; Bordoni, A; Ess, S; Franceschi, S
Blood, 113(): 5737-5742.
10.1182/blood-2009-02-204172
CrossRef
Current Hiv Research
Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4
Endo, M; Inatsu, A; Hashimoto, K; Takamune, N; Shoji, S; Misumi, S
Current Hiv Research, 6(1): 34-42.

Journal of Clinical Oncology
Multicenter study of human immunodeficiency virus-related germ cell tumors
Powles, T; Bower, M; Daugaard, G; Shamash, J; De Ruiter, A; Johnson, M; Fisher, M; Anderson, J; Mandalia, S; Stebbing, J; Nelson, M; Gazzard, B; Oliver, T
Journal of Clinical Oncology, 21(): 1922-1927.
10.1200/JCO.2003.09.107
CrossRef
Cancer
Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000
Johnson, LG; Madeleine, MM; Newcomer, LM; Schwartz, SM; Daling, JR
Cancer, 101(2): 281-288.
10.1002/cncr.20364
CrossRef
Journal of Clinical Oncology
Human immunodeficiency virus-associated squamous cell cancer of the anus: Epidemiology and outcomes in the highly active Antiretroviral therapy era
Chiao, EY; Giordano, TP; Richardson, P; El-Serag, HB
Journal of Clinical Oncology, 26(3): 474-479.
10.1200/JCO.2007.14.2810
CrossRef
Onkologie
Malignant melanoma and HIV infection - Aggressive Course despite Immune Reconstitution
Hoffmann, C; Horst, HA; Weichenthal, M; Hauschild, A
Onkologie, 28(1): 35-37.
10.1159/000082291
CrossRef
American Journal of Epidemiology
The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS
Hessol, NA; Pipkin, S; Schwarcz, S; Cress, RD; Bacchetti, P; Scheer, S
American Journal of Epidemiology, 165(): 1143-1153.
10.1093/aje/kwm017
CrossRef
Annals of Oncology
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
Hentrich, M; Maretta, L; Chow, KU; Bogner, JR; Schurmann, D; Neuhoff, P; Jager, H; Reichelt, D; Vogel, M; Ruhnke, M; Oette, M; Weiss, R; Rockstroh, J; Arasteh, K; Mitrou, P
Annals of Oncology, 17(6): 914-919.
10.1093/annonc/mdl063
CrossRef
Jama-Journal of the American Medical Association
Cancer incidence before and after kidney transplantation
Vajdic, CM; McDonald, SP; McCredie, MRE; van Leeuwen, MT; Stewart, JH; Law, M; Chapman, JR; Webster, AC; Kaldor, JM; Grulich, AE
Jama-Journal of the American Medical Association, 296(): 2823-2831.

Cancer Causes & Control
Spectrum of HIV/AIDS related cancers in India
Dhir, AA; Sawant, S; Dikshit, RP; Parikh, P; Srivastava, S; Badwe, R; Rajadhyaksha, S; Dinshaw, KA
Cancer Causes & Control, 19(2): 147-153.
10.1007/s10552-007-9080-y
CrossRef
Journal of the National Cancer Institute
Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
Clifford, GM; Polesel, J; Rickenbach, M; Dal Maso, L; Keiser, O; Kofler, A; Rapiti, E; Levi, F; Jundt, G; Fisch, T; Bordoni, A; De Weck, D; Franceschi, S
Journal of the National Cancer Institute, 97(6): 425-432.
10.1093/jnci/dji072
CrossRef
Lancet
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Grulich, AE; van Leeuwen, MT; Falster, M; Vajdic, CM
Lancet, 370(): 59-67.

AIDS Reader
Non-AIDS-defining cancers: Should antiretroviral therapy be initiated earlier?
Cinti, SK; Gandhi, T; Riddell, J
AIDS Reader, 18(1): 18-+.

Clinical Medicine
National review of deaths among HIV-infected adults
Lucas, SB; Curtis, H; Johnson, MA
Clinical Medicine, 8(3): 250-252.

Sexually Transmitted Infections
Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men
Vajdic, CM; van Leeuwen, MT; Jin, F; Prestage, G; Medley, G; Hillman, RJ; Stevens, MP; Botes, LP; Zablotska, I; Tabrizi, SN; Grulich, AE
Sexually Transmitted Infections, 85(5): 330-335.
10.1136/sti.2008.034744
CrossRef
Journal of Clinical Oncology
HIV As a Risk Factor for Lung Cancer in Women: Data From the Women's Interagency HIV Study
Levine, AM; Seaberg, EC; Hessol, NA; Preston-Martin, S; Silver, S; Cohen, MH; Anastos, K; Minkoff, H; Orenstein, J; Dominguez, G; Watts, DH
Journal of Clinical Oncology, 28(9): 1514-1519.
10.1200/JCO.2009.25.6149
CrossRef
American Journal of Epidemiology
Re: "Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus" - Reply
Grulich, AE; Law, MG
American Journal of Epidemiology, 157(): 955-956.

Archives of Internal Medicine
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus - A cohort study, 1992-2001
Giordano, TP; Kramer, JR; Souchek, J; Richardson, P; El-Serag, HB
Archives of Internal Medicine, 164(): 2349-2354.

Oncologist
AIDS-related malignancies: Emerging challenges in the era of highly active antiretroviral therapy
Cheung, MC; Pantanowitz, L; Dezube, BJ
Oncologist, 10(6): 412-426.

Cancer
Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals
Burgi, A; Brodine, S; Wegner, S; Milazzo, M; Wallace, MR; Spooner, K; Blazes, DL; Agan, BK; Armstrong, A; Fraser, S; Crum, NF
Cancer, 104(7): 1505-1511.
10.1002/cncr.21334
CrossRef
Revue De Medecine Interne
Cancers and HIV infection. Any association?
Bonnet, F; Morlat, P
Revue De Medecine Interne, 27(3): 227-235.
10.1016/j.revmed.2005.10.003
CrossRef
Thorax
Lung cancer in HIV infected patients: facts, questions and challenges
Cadranel, J; Garfield, D; Lavole, A; Wislez, M; Milleron, B; Mayaud, C
Thorax, 61(): 1000-1008.
10.1136/thx.2005.052373
CrossRef
Deutsche Medizinische Wochenschrift
High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany: analysis of data collected over a period of 3 years
Mosthaf, FA; Hanhoff, NJ; Goetzenich, A; Wolf, E; Knechten, H
Deutsche Medizinische Wochenschrift, 131(): 1849-1852.
10.1055/s-2006-949167
CrossRef
Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
Squamous Cell Carcinoma of the Anal Canal
Martin, FT; Kavanagh, D; Waldron, R
Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 7(4): 232-237.

International Journal of Std & AIDS
HIV-related testicular cancer
Powles, T; Nelson, M; Bower, M
International Journal of Std & AIDS, 14(1): 24-27.

Lancet Infectious Diseases
Epstein-Barr virus - recent advances
Macsween, KF; Crawford, DH
Lancet Infectious Diseases, 3(3): 131-140.

Journal of Clinical Oncology
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients
Herida, M; Mary-Krause, M; Kaphan, R; Cadranel, J; Poizot-Martin, I; Rabaud, C; Plaisance, N; Tissot-Dupont, H; Boue, F; Lang, JM; Costagliola, D
Journal of Clinical Oncology, 21(): 3447-3453.
10.1200/JCO.2003.01.096
CrossRef
British Journal of Cancer
The risk of cancer in HIV-infected people in southeast England: a cohort study
Newnham, A; Harris, J; Evans, HS; Evans, BG; Moller, H
British Journal of Cancer, 92(1): 194-200.
10.1038/sj.bjc.6602273
CrossRef
Bulletin Du Cancer
Epidemiology of HIV-associated malignancies
Launay, O; Guillevin, L
Bulletin Du Cancer, 90(5): 387-392.

Hiv Medicine
Lung cancer in patients with HIV infection: is it AIDS-related?
Burke, M; Furman, A; Hoffman, M; Marmor, S; Blum, A; Yust, I
Hiv Medicine, 5(2): 110-114.

Lancet
The changing face of the HIV epidemic in western Europe: what are the implications for public health policies?
Hamers, FF; Downs, AM
Lancet, 364(): 83-94.

Journal of Clinical Oncology
Which one is better: AIDS related or HIV associated?
Abali, H; Abali, G; Aksoy, S
Journal of Clinical Oncology, 25(6): E6.
10.1200/JCO.2006.09.0498
CrossRef
Annals of Internal Medicine
Incidence of types of cancer among HIV-Infected persons compared with the general population in the United States, 1992-2003
Patel, P; Hanson, DL; Sullivan, PS; Novak, RM; Moorman, AC; Tong, TC; Holmberg, SD; Brooks, JT
Annals of Internal Medicine, 148(): 728-U29.

Cochrane Database of Systematic Reviews
Interventions for previously untreated patients with AIDS-associated Non-Hodgkin's Lymphoma
Marti-Carvajal, AJ; Cardona, AF; Lawrence, A
Cochrane Database of Systematic Reviews, (3): -.
ARTN CD005419
CrossRef
Head and Neck-Journal for the Sciences and Specialties of the Head and Neck
Primary Squamous Cell Carcinoma of Stensen's Duct in A Patient With Hiv: the Role of Magnetic Resonance Imaging and Fine-Needle Aspiration
Kim, TB; Klein, HZ; Glastonbury, CM; Eisele, DW
Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 31(2): 278-282.
10.1002/hed.20889
CrossRef
Internal Medicine
Germ Cell Tumor Concomitant with Acquired Immune Deficiency Syndrome
Ochi, T; Azuma, T; Takada, K; Fujiwara, H; Teraoka, H; Ueda, Y; Yakushijin, Y; Hato, T; Hasegawa, H; Yasukawa, M
Internal Medicine, 48(): 2129-2132.
10.2169/internalmedicine.48.2357
CrossRef
Transfusion and Apheresis Science
Human immunodeficiency and Hodgkin lymphoma
Sissolak, G; Sissolak, D; Jacobs, P
Transfusion and Apheresis Science, 42(2): 131-139.
10.1016/j.transci.2010.01.008
CrossRef
British Journal of Cancer
Pattern of cancer risk in persons with AIDS in Italy in the HAART era
Dal Maso, L; Polesel, J; Serraino, D; Lise, M; Piselli, P; Falcini, F; Russo, A; Intrieri, T; Vercelli, M; Zambon, P; Tagliabue, G; Zanetti, R; Federico, M; Limina, RM; Mangone, L; De Lisi, V; Stracci, F; Ferretti, S; Piffer, S; Budroni, M; Donato, A; Giacomin, A; Bellu, F; Fusco, M; Madeddu, A; Vitarelli, S; Tessandori, R; Tumino, R; Suligoi, B; Franceschi, S
British Journal of Cancer, 100(5): 840-847.
10.1038/sj.bjc.6604923
CrossRef
Lancet Oncology
Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS
Dal Maso, L; Franceschi, S
Lancet Oncology, 4(2): 110-119.

Cancer
Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the greater San Francisco Bay Area, 1988-1998
Glaser, SL; Clarke, CA; Gulley, ML; Craig, FE; DiGiuseppe, JA; Dorfman, RF; Mann, RB; Ambinder, RF
Cancer, 98(2): 300-309.
10.1002/cncr.11459
CrossRef
AIDS
Lung cancer in persons with AIDS in Italy, 1985-1998
Dal Maso, L; Polesel, J; Serraino, D; Franceschi, S
AIDS, 17(): 2117-2119.
10.1097/01.aids.0000088179.01779.fd
CrossRef
Clinical Infectious Diseases
Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002
Bedimo, R; Chen, RY; Accortt, NA; Raper, JL; Linn, C; Allison, JJ; Dubay, J; Saag, MS; Hoesley, CJ
Clinical Infectious Diseases, 39(9): 1380-1384.

Frontiers in Bioscience
Acquired immunodeficiency syndrome associated lymphoma
Bertrand, FE; McCubrey, JA
Frontiers in Bioscience, 10(): 2972-2977.

International Journal of Cancer
Cancer risk in people infected with human immunodeficiency virus in the United States
Engels, EA; Biggar, RJ; Hall, HI; Cross, H; Crutchfield, A; Finch, JL; Griggs, R; Hylton, T; Pawlish, KS; McNeel, TS; Goedert, JJ
International Journal of Cancer, 123(1): 187-194.
10.1002/ijc.23487
CrossRef
Seminars in Hematology
Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host
Little, RF; Yarchoan, R
Seminars in Hematology, 40(2): 163-171.
10.1053/shem.2003.50016
CrossRef
International Journal of Cancer
Spectrum of cancers among HIV-infected persons in Africa: The Uganda AIDS-cancer registry match study
Mbulaiteye, SM; Katabira, ET; Wabinga, H; Parkin, DM; Virgo, P; Ochai, R; Workneh, M; Coutinho, A; Engels, EA
International Journal of Cancer, 118(4): 985-990.
10.1002/ijc.21443
CrossRef
Journal of the American Academy of Dermatology
Cutaneous malignancy and human immunodeficiency virus disease
Wilkins, K; Turner, R; Dolev, JC; LeBoit, PE; Berger, TG; Maurer, TA
Journal of the American Academy of Dermatology, 54(2): 189-206.
10.1016/j.jaad.2004.11.060
CrossRef
British Journal of Cancer
Risk of breast, ovary, and uterine corpus cancers among 85 268 women with AIDS
Goedert, JJ; Schairer, C; McNeel, TS; Hessol, NA; Rabkin, CS; Engels, EA
British Journal of Cancer, 95(5): 642-648.
10.1038/sj.bjc.6603282
CrossRef
Blood
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, RJ; Jaffe, ES; Goedert, JJ; Chaturvedi, A; Pfeiffer, R; Engels, EA
Blood, 108(): 3786-3791.
10.1182/blood-2006-05-024109
CrossRef
Acta Haematologica
Effect of L-Asparaginase Combined with Vincristine and Prednisolone on Acute Myeloblastic Leukemia (M0) Associated with Non-Hodgkin Lymphoma
Horikoshi, A; Takei, K; Iriyama, N; Uenogawa, K; Ishizuka, H; Shiraiwa, H; Hosokawa, Y; Sawada, S; Kitoh, T
Acta Haematologica, 122(1): 54-57.
10.1159/000243725
CrossRef
Lancet
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A; Ledergerber, B; Katlama, C; Kirk, O; Reiss, P; Monforte, AD; Knsyz, B; Dietrich, M; Phillips, AN; Lundgren, JD
Lancet, 362(): 22-29.

Journal of Laryngology and Otology
Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus
Powles, T; Powles, J; Nelson, M; Sandison, A; Peston, D; Buchannan, J; Mandalia, S; Gazzard, B; Bower, M
Journal of Laryngology and Otology, 118(3): 207-212.

Leukemia & Lymphoma
Plasma cell tumors in HIV-positive patients: Report of a case and review of the literature
Salarieh, A; Rao, C; Gottesman, SRS; Alagha, O; Todor, R; Axiotis, CA
Leukemia & Lymphoma, 46(7): 1067-1074.

Hiv Medicine
Serum prostate-specific antigen levels in older men with or at risk of HIV infection
Vianna, LE; Lo, Y; Klein, RS
Hiv Medicine, 7(7): 471-476.

International Journal of Cancer
Cancer and viral infections in immunocompromised individuals
Schulz, TF
International Journal of Cancer, 125(8): 1755-1763.
10.1002/ijc.24741
CrossRef
Oncology Reports
HIV infection and cancer in the era of highly active antiretroviral therapy (Review)
Barbaro, G; Barbarini, G
Oncology Reports, 17(5): 1121-1126.

Hiv Medicine
British HIV Association guidelines for HIV-associated malignancies 2008
Bower, M; Collins, S; Cottrill, C; Cwynarski, K; Montoto, S; Nelson, M; Nwokolo, N; Powles, T; Stebbing, J; Wales, N; Webb, A
Hiv Medicine, 9(6): 336-388.
10.1111/j.1468-1293.2008.00608.x
CrossRef
Clinical Colorectal Cancer
Human Immunodeficiency Virus-Associated Adenocarcinoma of the Colon: Clinicopathologic Findings and Outcome
Chapman, C; Aboulafia, DM; Dezube, BJ; Pantanowitz, L
Clinical Colorectal Cancer, 8(4): 215-219.
10.3816/CCC.2009.n.036
CrossRef
Plos One
The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa
Sasco, AJ; Jaquet, A; Boidin, E; Ekouevi, DK; Thouillot, F; LeMabec, T; Forstin, MA; Renaudier, P; N'Dom, P; Malvy, D; Dabis, F
Plos One, 5(1): -.
ARTN e8621
CrossRef
Infections in Medicine
AIDS-related non-Hodgkin lymphorna: Evolving clinical issues in the HAART era
Aboulafia, DM
Infections in Medicine, 24(): 445-451.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi
Seroprevalence of HTLV I-II, HIV and HCV Antibodies in Lymphoma, Head and Neck Cancer Patients
Buyukberber, N; Yalcinkaya, T; Yildiz, R; Coskun, U; Benekli, M
Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, 22(4): 239-244.
10.4999/uhod.12061
CrossRef
Journal of Medical Virology
Testicular Cancer and Viral Infections: A Systematic Literature Review and Meta-Analysis
Yousif, L; Hammer, GP; Blettner, M; Zeeb, H
Journal of Medical Virology, 85(): 2165-2175.
10.1002/jmv.23704
CrossRef
AIDS
Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States
Engels, EA; Lanoy, E; Dores, GM; Madeleine, MM; Toro, JR; Fraumeni, JF
AIDS, 23(3): 385-393.
10.1097/QAD.0b013e3283213046
PDF (171) | CrossRef
AIDS
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
CASCADE Collaboration,
AIDS, 20(5): 741-749.
10.1097/01.aids.0000216375.99560.a2
PDF (194) | CrossRef
AIDS
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy
van Leeuwen, MT; Vajdic, CM; Middleton, MG; McDonald, AM; Law, M; Kaldor, JM; Grulich, AE
AIDS, 23(16): 2183-2190.
10.1097/QAD.0b013e328331d384
PDF (335) | CrossRef
AIDS
HIV infection and the risk of cancers with and without a known infectious cause
Silverberg, MJ; Chao, C; Leyden, WA; Xu, L; Tang, B; Horberg, MA; Klein, D; Quesenberry, CP; Towner, WJ; Abrams, DI
AIDS, 23(17): 2337-2345.
10.1097/QAD.0b013e3283319184
PDF (401) | CrossRef
Current Opinion in Infectious Diseases
Non-AIDS-defining cancers
Stebbing, J; Duru, O; Bower, M
Current Opinion in Infectious Diseases, 22(1): 7-10.
10.1097/QCO.0b013e3283213080
PDF (79) | CrossRef
Current Opinion in Oncology
Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus
Carraway, H; Ambinder, RF
Current Opinion in Oncology, 14(5): 543-545.

PDF (162)
Current Opinion in Oncology
AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era
Silverberg, MJ; Abrams, DI
Current Opinion in Oncology, 19(5): 446-451.
10.1097/CCO.0b013e3282c8c90d
PDF (114) | CrossRef
Current Opinion in Oncology
Evolving epidemiology of malignancies in HIV
Bonnet, F; Chêne, G
Current Opinion in Oncology, 20(5): 534-540.
10.1097/CCO.0b013e32830a5080
PDF (126) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4
Fontas, E; Kousignian, I; Pradier, C; Duvivier, C; Poizot-Martin, I; Durier, C; Jarrousse, B; Weiss, L; Levy, Y; Costagliola, D; on behalf of the FHDH ANRS CO4 ANRS CO141,
JAIDS Journal of Acquired Immune Deficiency Syndromes, 50(2): 206-214.
10.1097/QAI.0b013e318190018c
PDF (187) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Immune Deficiency and Risk for Malignancy Among Persons with AIDS
Mbulaiteye, SM; Biggar, RJ; Goedert, JJ; Engels, EA
JAIDS Journal of Acquired Immune Deficiency Syndromes, 32(5): 527-533.

PDF (333)
JAIDS Journal of Acquired Immune Deficiency Syndromes
Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study
D'Souza, G; Wiley, DJ; Li, X; Chmiel, JS; Margolick, JB; Cranston, RD; Jacobson, LP
JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(4): 491-499.
10.1097/QAI.0b013e31817aebfe
PDF (162) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Population-Based Surveillance of HIV-Associated Cancers: Utility of Cancer Registry Data
Clarke, CA; Glaser, SL
JAIDS Journal of Acquired Immune Deficiency Syndromes, 36(5): 1083-1091.

PDF (85)
JAIDS Journal of Acquired Immune Deficiency Syndromes
Incidence of AIDS-Defining Cancers After AIDS Diagnosis Among People with AIDS in Italy, 1986–1998
Franceschi, S; Dal Maso, L; Pezzotti, P; Polesel, J; Braga, C; Piselli, P; Serraino, D; Tagliabue, G; Federico, M; Ferretti, S; De Lisi, V; La Rosa, F; Conti, E; Budroni, M; Vicario, G; Piffer, S; Pannelli, F; Giacomin, A; Bellù, F; Tumino, R; Fusco, M; Rezza, G; Cancer and AIDS Registry Linkage Study,
JAIDS Journal of Acquired Immune Deficiency Syndromes, 34(1): 84-90.

PDF (385)
JAIDS Journal of Acquired Immune Deficiency Syndromes
Letters to the Editor: Increased Incidence of Lung Neoplasms Among HIV-Infected Men and the Need for Improved Prevention
Cailhol, J; Calatroni, M; Roudière, L; Aaron, L; Viard, J
JAIDS Journal of Acquired Immune Deficiency Syndromes, 34(2): 247-249.

PDF (2339)
JAIDS Journal of Acquired Immune Deficiency Syndromes
A Population-Based Analysis of Temporal Trends in the Incidence of Squamous Anal Canal Cancer in Relation to the HIV Epidemic
Chiao, EY; Krown, SE; Stier, EA; Schrag, D
JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(4): 451-455.

PDF (314)
JAIDS Journal of Acquired Immune Deficiency Syndromes
A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals
Shiels, MS; Cole, SR; Kirk, GD; Poole, C
JAIDS Journal of Acquired Immune Deficiency Syndromes, 52(5): 611-622.
10.1097/QAI.0b013e3181b327ca
PDF (220) | CrossRef
Journal of Clinical Gastroenterology
Effect of HIV Infection on the Prevalence of Colorectal Adenomas During Screening Colonoscopy
Kothari, ND; Engelson, ES; Drake, V; Mehdi, A; Ionescu, G; Kotler, DP
Journal of Clinical Gastroenterology, 44(1): 77-78.
10.1097/MCG.0b013e3181a1f5b5
PDF (83) | CrossRef
Journal of Thoracic Oncology
Interactions Between Cytotoxic Chemotherapy and Antiretroviral Treatment in Human Immunodeficiency Virus-Infected Patients with Lung Cancer
Makinson, A; Pujol, J; Le Moing, V; Peyriere, H; Reynes, J
Journal of Thoracic Oncology, 5(4): 562-571.
10.1097/JTO.0b013e3181d3ccf2
PDF (414) | CrossRef
Sexually Transmitted Diseases
What Do Gay Men Know About Human Papillomavirus? Australian Gay Men's Knowledge and Experience of Anal Cancer Screening and Human Papillomavirus
Pitts, MK; Fox, C; Willis, J; Anderson, J
Sexually Transmitted Diseases, 34(3): 170-173.
10.1097/01.olq.0000230436.83029.ce
PDF (150) | CrossRef
Sexually Transmitted Diseases
Increased Incidence of Squamous Cell Anal Cancer Among Men With AIDS in the Era of Highly Active Antiretroviral Therapy
Diamond, C; Taylor, TH; Aboumrad, T; Bringman, D; Anton-Culver, H
Sexually Transmitted Diseases, 32(5): 314-320.

PDF (245)
Back to Top | Article Outline
Keywords:

cancers; epidemiology; homosexual men; risk factors

© 2002 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.